Login / Signup

Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials.

Richard B LiptonRashmi B Halker SinghDennis A RevickiSihui ZhaoAnand S ShewaleJordan E LateinerDavid W Dodick
Published in: The journal of headache and pain (2022)
ClinicalTrials.gov: NCT02828020 (ACHIEVE I), registered July 11, 2016; NCT02867709 (ACHIEVE II), registered August 16, 2016.
Keyphrases
  • respiratory failure
  • intensive care unit
  • drug induced
  • aortic dissection
  • hepatitis b virus